Odefsey Prices, Coupons and Patient Assistance Programs
Odefsey (emtricitabine/rilpivirine/tenofovir alafenamide) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.
Odefsey Prices
This Odefsey price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Odefsey oral tablet (200 mg-25 mg-25 mg) is around $3,086 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Odefsey is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Odefsey availability.
Oral Tablet
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $102.88 | $3,086.28 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Odefsey Coupons and Rebates
Odefsey offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Odefsey Advancing Access Co-pay Program: Commercially insured patients may save up to a maximum of $6000 per year; for additional information contact the program at 800-226-2056.
| Applies to: | Odefsey |
| Number of uses: | per prescription per year |
Patient Assistance Programs for Odefsey
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Advancing Access Program
Elligibility requirements:
- Must be uninsured or underinsured
- At or below 500% of FPL
- Medically appropriate condition/diagnosis
- Must be residing in the US or Puerto Rico
- This program is for outpatient use only. Insurance benefits, claims assistance and/or other reimbursement help is offered. *Viread: Contact program for details This Program participates in the CPAPA. This single common application allows uninsured HIV-positive individuals with low incomes to use one application to apply for multiple assistance programs. IMPORTANT: Send completed CPAPA to the corresponding addresses listed for each company. This program also provides copay assistance.
Applicable drugs:
- Odefsey (emtricitabine-rilpivirine-tenofovir alafenamide) Tablet
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Odefsey (emtricitabine-rilpivirine-tenofovir alafenamide) Tablet
Provider: Good Days Program
Elligibility requirements:
- Must have insurance
- At or below 500% of FPL
- FDA-approved diagnosis
- The patient must also be a US resident with a Social Security Number.
- Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
Applicable drugs:
- Odefsey (emtricitabine-rilpivirine-tenofovir alafenamide) Tablet
Provider: Advancing Access Uninsured 24/7 Support
Elligibility requirements:
- Determined case by case
- Varies
- Medically Necessary as determined by a Doctor
- US residency requirements are not specified.
- Free Trial, Co-payment and patient assistance programs are available for eligible patients. Please visit www.GileadAdvancingAccess.com or call 1-800-226-2056 (24/7) for more information.
Applicable drugs:
- Odefsey (emtricitabine-rilpivirine-tenofovir alafenamide) Tablet
More about Odefsey (emtricitabine / rilpivirine / tenofovir alafenamide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- 6 Reviews
- Drug class: antiviral combinations
- FDA Approval History
